Document Detail


Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study.
MedLine Citation:
PMID:  17395895     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cannabinoid receptors (CBR) are located on cholinergic neurons in the brain stem, stomach, and colon. CBR stimulation inhibits motility in rodents. Effects in humans are unclear. Dronabinol (DRO), a nonselective CBR agonist, inhibits colonic motility and sensation. The aim of this study was to compare effects of DRO and placebo (PLA) on colonic motility and sensation in healthy volunteers. Fifty-two volunteers were randomly assigned (double-blind) to a single dose of 7.5 mg DRO or PLA postoperative with concealed allocation. A balloon-manometric assembly placed into the descending colon allowed assessment of colonic compliance, motility, tone, and sensation before and 1 h after oral ingestion of medication, and during fasting, and for 1 h after 1,000-kcal meal. There was an overall significant increase in colonic compliance (P = 0.045), a borderline effect of relaxation in fasting colonic tone (P = 0.096), inhibition of postprandial colonic tone (P = 0.048), and inhibition of fasting and postprandial phasic pressure (P = 0.008 and 0.030, respectively). While DRO did not significantly alter thresholds for first gas or pain sensation, there was an increase in sensory rating for pain during random phasic distensions at all pressures tested and in both genders (P = 0.024). In conclusion, in humans the nonselective CBR agonist, DRO, relaxes the colon and reduces postprandial colonic motility and tone. Increase in sensation ratings to distension in the presence of relaxation of the colon suggests central modulation of perception. The potential for CBR to modulate colonic motor function in diarrheal disease such as irritable bowel syndrome deserves further study.
Authors:
Tuba Esfandyari; Michael Camilleri; Irene Busciglio; Duane Burton; Kari Baxter; Alan R Zinsmeister
Related Documents :
12850685 - Effect of colonic distention on ileal motor activity with evidence of coloileal reflex.
1734695 - Manometric characteristics in idiopathic and reflux-associated esophageal spasm.
21414565 - Efficacy and safety of aliskiren-based dual and triple combination therapies in us mino...
16077405 - On the pathogenesis of gastroesophageal reflux: the concept of gastroesophageal dyssyne...
12850685 - Effect of colonic distention on ileal motor activity with evidence of coloileal reflex.
106985 - Baroreceptor control of atrioventricular conduction in man.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural     Date:  2007-03-29
Journal Detail:
Title:  American journal of physiology. Gastrointestinal and liver physiology     Volume:  293     ISSN:  0193-1857     ISO Abbreviation:  Am. J. Physiol. Gastrointest. Liver Physiol.     Publication Date:  2007 Jul 
Date Detail:
Created Date:  2007-07-06     Completed Date:  2007-09-12     Revised Date:  2007-12-03    
Medline Journal Info:
Nlm Unique ID:  100901227     Medline TA:  Am J Physiol Gastrointest Liver Physiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  G137-45     Citation Subset:  IM    
Affiliation:
Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Colon / drug effects*,  innervation,  physiology*
Compliance / drug effects
Fasting
Female
Gastrointestinal Transit / drug effects*
Humans
Male
Pain
Receptors, Cannabinoid / agonists*
Sensory Thresholds / drug effects
Tetrahydrocannabinol / pharmacology*
Grant Support
ID/Acronym/Agency:
K24 DK 02638/DK/NIDDK NIH HHS; R01 DK 54681/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
0/Receptors, Cannabinoid; 1972-08-3/Tetrahydrocannabinol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Single-dose pharmacokinetics of multilayer-release methylphenidate and immediate-release methylpheni...
Next Document:  Interleukin-6 inhibits growth hormone-mediated gene expression in hepatocytes.